Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I study of a DNA-based vaccine targeting prostatic acid phosphatase (PAP) in patients with stage D0 prostate cancer.

Trial Profile

Phase I study of a DNA-based vaccine targeting prostatic acid phosphatase (PAP) in patients with stage D0 prostate cancer.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Prostate cancer vaccine (Primary) ; Granulocyte macrophage colony stimulating factor
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 27 Sep 2010 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
    • 19 Apr 2009 Status changed from active, no longer recruiting to completed, as reported in bstract number 729 presented at the 100th Annual Meeting of the American Association for Cancer Research (AACR), held in Denver, Colorado, USA in April 2009.
    • 18 Apr 2009 Primary outcome amended as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top